Lombard Odier Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Lombard Odier Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Lombard Odier Asset Management from 13F filings

Historical chart of Lombard Odier Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Lombard Odier Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Lombard Odier Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $21M 16M 1.33
2024-09-30 $16M 13M 1.19
2023-09-30 $3.6M 3.8M 0.94

More positions owned by Lombard Odier Asset Management

Alphabet Cap Stk Cl A Call Option (GOOGL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Live Nation Entertainment In Note 2.875% 1/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Coinbase Global Note 0.250% 4/0 (Principal)
Centerpoint Energy Note 4.250% 8/1 (Principal)
Nextera Energy (NEE)
Ecolab (ECL)
Thermo Fisher Scientific (TMO)
Rivian Automotive Note 3.625%10/1 (Principal)
Manulife Finl Corp (MFC)
Crown Holdings (CCK)

View all positions for Lombard Odier Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
Point72 Asset Management
LMR Partners
Balyasny Asset Management
Alberta Investment Management Corporation
Jain Global
Jpmorgan Chase & Co
Lazard Asset Management
Lombard Odier Asset Management
Absolute Investment Advisers
Citadel Advisors
Linden Advisors
Calamos Advisors
Tenor Capital Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1